-
Je něco špatně v tomto záznamu ?
Therapeutic potential of hepcidin - the master regulator of iron metabolism
D. Vyoral, . Jiri Petrak,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NV15-32961A
MZ0
CEP - Centrální evidence projektů
- MeSH
- hepcidiny farmakologie terapeutické užití MeSH
- homeostáza účinky léků MeSH
- lidé MeSH
- proteiny přenášející kationty metabolismus MeSH
- železo metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Iron is an essential biogenic element for both prokaryotic and eukaryotic cells. In humans iron is present in hundreds of different metalloproteins. The peptide hormone hepcidin serves as a master regulator of iron homeostasis on the level of single cells and whole organism - by altering cell surface expression of cellular iron exporter - protein ferroportin. Altered levels of extracellular hepcidin lead to pathological conditions such as hemochromatosis and iron loading or, on the other side, iron restrictive anemias. Therapeutic modulation of hepcidin is a new and promising approach to treatment of these conditions. In this review, a summary of the current knowledge of hepcidin function, regulation and pathological involvements are provided, followed by a section covering the therapeutic potential of hepcidin and the current strategies how to modulate its levels and biological functions for therapeutic purposes.
BIOCEV 1st Faculty of Medicine Charles University Prague Czechia
Institute of Hematology and Blood Transfusion Prague Czechia
Institute of Pathological Physiology 1st Faculty of Medicine Charles University Prague Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016905
- 003
- CZ-PrNML
- 005
- 20180515103417.0
- 007
- ta
- 008
- 180515s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.phrs.2016.11.010 $2 doi
- 035 __
- $a (PubMed)27867027
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vyoral, Daniel $u Institute of Hematology and Blood Transfusion, Prague, Czechia; Institute of Pathological Physiology, First Faculty of Medicine,Charles University, Prague, Czechia. Electronic address: vyoral@uhkt.cz.
- 245 10
- $a Therapeutic potential of hepcidin - the master regulator of iron metabolism / $c D. Vyoral, . Jiri Petrak,
- 520 9_
- $a Iron is an essential biogenic element for both prokaryotic and eukaryotic cells. In humans iron is present in hundreds of different metalloproteins. The peptide hormone hepcidin serves as a master regulator of iron homeostasis on the level of single cells and whole organism - by altering cell surface expression of cellular iron exporter - protein ferroportin. Altered levels of extracellular hepcidin lead to pathological conditions such as hemochromatosis and iron loading or, on the other side, iron restrictive anemias. Therapeutic modulation of hepcidin is a new and promising approach to treatment of these conditions. In this review, a summary of the current knowledge of hepcidin function, regulation and pathological involvements are provided, followed by a section covering the therapeutic potential of hepcidin and the current strategies how to modulate its levels and biological functions for therapeutic purposes.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a proteiny přenášející kationty $x metabolismus $7 D027682
- 650 _2
- $a hepcidiny $x farmakologie $x terapeutické užití $7 D064451
- 650 _2
- $a homeostáza $x účinky léků $7 D006706
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a železo $x metabolismus $7 D007501
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Jiri Petrak, $u BIOCEV, First Faculty of Medicine, Charles University, Prague, Czechia; Institute of Hematology and Blood Transfusion, Prague, Czechia.
- 773 0_
- $w def $t Pharmacological research $x 1096-1186 $g Roč. 115, č. - (2017), s. 242-254
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27867027 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515103551 $b ABA008
- 999 __
- $a ok $b bmc $g 1300529 $s 1013745
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 115 $c - $d 242-254 $e 20161117 $i 1096-1186 $m Pharmacological research $n Pharmacol Res $x MED00005744
- GRA __
- $a NV15-32961A $p MZ0
- LZP __
- $a Pubmed-20180515